Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-01
DOI
10.1038/srep20208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer
- (2014) Chia-Huei Lee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling
- (2013) Malin Lando et al. JOURNAL OF PATHOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo
- (2012) Lan Qian et al. BIOMEDICINE & PHARMACOTHERAPY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification
- (2011) Zhe Hou et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Genome-wide analysis reveals the active roles of keratinocytes in oral mucosal adaptive immune response
- (2011) Tong Wu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts
- (2011) József Dudás et al. EXPERIMENTAL CELL RESEARCH
- Role of interleukin 1 beta in esophageal squamous cell carcinoma
- (2011) Miao-Fen Chen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation
- (2011) Kelly Casós et al. MICROVASCULAR RESEARCH
- Why not treat human cancer with interleukin-1 blockade?
- (2010) Charles A. Dinarello CANCER AND METASTASIS REVIEWS
- Tamoxifen, Flaxseed, and the Lignan Enterolactone Increase Stroma- and Cancer Cell-Derived IL-1Ra and Decrease Tumor Angiogenesis in Estrogen-Dependent Breast Cancer
- (2010) G. Lindahl et al. CANCER RESEARCH
- T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
- (2010) A. E. Albers et al. Clinical & Developmental Immunology
- Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)
- (2010) H. El-Osta et al. MOLECULAR CANCER THERAPEUTICS
- Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma
- (2009) M. A. St. John et al. CLINICAL CANCER RESEARCH
- Fibroblast Growth Factor Receptor 2-Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma
- (2009) C. Zhang et al. CLINICAL CANCER RESEARCH
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More